SKF 86002 dihydrochloride
Modify Date: 2026-06-30 17:50:26
SKF 86002 dihydrochloride structure
|
Common Name | SKF 86002 dihydrochloride | ||
|---|---|---|---|---|
| CAS Number | 116339-68-5 | Molecular Weight | 370.272 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H14Cl2FN3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SKF 86002 dihydrochlorideSKF-86002 dihydrochloride is an orally active p38 MAPK inhibitor, with anti-inflammatory, anti-arthritic and analgesic activities. SKF-86002 dihydrochloride inhibits lipopolysaccharide (LPS)-stimulate human monocyte IL-1 and TNF-α production (IC50 = 1 μM). SKF-86002 dihydrochloride inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid[1][2][3]. |
| Name | SKF 86002 dihydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | SKF-86002 dihydrochloride is an orally active p38 MAPK inhibitor, with anti-inflammatory, anti-arthritic and analgesic activities. SKF-86002 dihydrochloride inhibits lipopolysaccharide (LPS)-stimulate human monocyte IL-1 and TNF-α production (IC50 = 1 μM). SKF-86002 dihydrochloride inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | SKF-86002 dihydrochloride (10 μM; 1 hour) inhibits apoptosis induced by stress stimulation with UV irradiation (UV)[1]. SKF-86002 dihydrochloride does not inhibit UV-induced apoptosis in undifferentiated HL-60 cells[1]. SKF-86002 dihydrochloride (10 μM; 72 hours) prevent IL-4-induced monocyte or U937 cell CD23 surface expression and protein formation with no effect on CD23 mRNA levels[4]. Western Blot Analysis[4] Cell Line: U937 cells Concentration: 10 μM Incubation Time: 72 hours Result: Reduced CD23 levels on IL-4-treated U937 cells. |
| In Vivo | SKF-86002 dihydrochloride (10-90 mg/kg; p.o.; daily; for 22 days) has antiarthritic activity[5]. Animal Model: Lewis rats, with adjuvant-induced arthritis (AA)[5] Dosage: 10 mg/kg, 30 mg/kg, 90 mg/kg Administration: Oral administration, daily, for 22 days Result: Significantly decreased hindleg volumes after injection of adjuvant. |
| References |
| Molecular Formula | C16H14Cl2FN3S |
|---|---|
| Molecular Weight | 370.272 |
| Exact Mass | 369.026947 |
| Appearance of Characters | powder |
| InChIKey | GQQCNUNCYVXBTF-UHFFFAOYSA-N |
| SMILES | Cl.Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1 |
| Storage condition | Store at -20°C |
| Water Solubility | Soluble to 50 mM in sterile water |
| Hazard Codes | Xi |
|---|
|
Name: Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident pro...
Source: NCGC
Target: N/A
External Id: SERCaMPGLuc-p1-antagonist
|
|
Name: High Throughput Screening for Foot and Mouth Disease Virus Antivirals
Source: NCGC
Target: N/A
External Id: StopGo1
|
|
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VER...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4513082
|
|
Name: Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Cac...
Source: ChEMBL
Target: Severe acute respiratory syndrome coronavirus 2
External Id: CHEMBL4303805
|
|
Name: SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response f...
Source: ChEMBL
Target: Replicase polyprotein 1ab
External Id: CHEMBL4495582
|
|
Name: Tocris HTS for Inhibitors of Aerobactin Synthetase lucA
Source: 23265
External Id: IucA Pilot Assay Tocris Library
|
Total 6, Current Page 1 of 1
1
| 6-(4-Fluorophenyl)-5-(4-pyridinyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole dihydrochloride |
| 6-(4-Fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole dihydrochloride |
| Imidazo[2,1-b]thiazole, 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)-, hydrochloride (1:2) |